extraordinary general meeting of shareholders on November 21, 2017 for consideration and approval of the capital increase of a number of 100 million shares by right offering (RO) to existing shareholders at a

3.4 billion less final dividend THB 0.8 billion 2016 paid in Q217, interim dividend Q417 THB 0.8 billion, capital expenditure THB 1.1 billion, other items THB -0.9 billion. Cash and financial

according to the proportion of income according to the specified plan In addition, the company has measured fair value of PPA (Perchase Price Allocation) of WICE Logistics (Hong Kong) with intangible assets

into the sign of Share Sale and Purchase Agreement, including transfer of related brand names from the selling shareholder(s). According to the Notification of the Capital Market Supervisory Board No

, including transfer of related brand names from the selling shareholder(s). According to the Notification of the Capital Market Supervisory Board No. TorChor. 20/2551 Re: Rules on Entering into Material

Assets B.E. 2 5 4 7 and as amended by the announcement of the Board of Directors. Capital Market Supervisory Board No. ThorJor. Resource assets When calculating the size of the transaction according to the

% of paid up capital, Total investment 50 Millions baht. The acquisition of BS Myco Biotech shares will result in the BS Myco Biotech being a subsidiary of the Company. The Company signed the share

23,500,000 ordinary shares (or approximately equivalent to 29.38% of total paid-up capital after the IPO Plan) to the public for the purpose of IPO Plan in TWSE. In addition, the Company will provide not more

restated due to adjustments in fair value of capital invested in geothermal power plant project in Indonesia Performance of the first 6 months of 2019, Bangchak Corporation Plc. (“the Company”) and its

., Ltd. in 99,997 shares which is 99.997% of the capital at 10.00 Baht per share (par value) in total value of 999,970.00 Baht. 2. There is an approval with authorization to board of executive directors to